Armenia vs Costa Rica: New cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Costa Rica
100.0%
in 2024
Armenia rank
1st
Costa Rica rank
1st
New cases tested for RR-/MDR-TB over time
- Armenia
- Costa Rica
How they compare
Armenia currently reports 100.0% against 100.0% in Costa Rica, a difference of 0.0%.
The two have swapped places 7 times across 15 shared years of data; in 2005 it was Armenia ahead.
Armenia ranks 1st and Costa Rica ranks 1st of 192 countries.
Armenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Armenia | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.5% | 0.2% | 84.3% | Armenia |
| 2010s | 95.9% | 52.1% | 43.8% | Armenia |
| 2020s | 100.0% | 70.8% | 29.2% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Armenia or Costa Rica?
- Armenia, at 100.0% against 100.0% in Costa Rica as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Armenia and Costa Rica?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Costa Rica?
- 15 years are reported by both, from 2005 to 2024.
- How do Armenia and Costa Rica rank globally for new cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Costa Rica ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.